 |
| Christopher Viehbacher |
CED, the southeast’s largest entrepreneurial support organization, today announced that Christopher Viehbacher, CEO of Sanofi, will be the opening keynote speaker for the 21st annual CED Life Science Conference, to be held Feb 15-16, 2012, at the Raleigh Convention Center.
The conference chairs are Victor J. Dzau, MD, chancellor for health affairs at Duke University and president and CEO of Duke University Health System, and Robert A. Ingram, general partner, Hatteras Venture Partners.
Other speakers confirmed for the conference include Alex Gorsky, vice chairman, Johnson & Johnson; Bill Hawkins, retired chairman and CEO, Medtronic, Inc.; Kris H. Jenner, vice president, T. Rowe Price Group; and Jeremy Levin, senior vice president, strategy, alliances and transactions, Bristol-Myers Squib.
“This conference represents the largest gathering in the southeast of the region’s life science community,” said Joan Siefert Rose, CED president. “We are excited to present a top-tier line-up of speakers for this event, which showcases a robust industry for North Carolina.”
The CED Life Science Conference is presented in partnership with the North Carolina Biotechnology Center and North Carolina Biosciences. Early registration and a full conference agenda are online at http://www.cednc.org/lifescience.
